Back to Search Start Over

Novavax's Nuvaxovid Covid-19 vaccine receives conditional marketing authorization from European Commission

Source :
PharmaBiz. December 22, 2021
Publication Year :
2021

Abstract

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the European Commission (EC) has granted Novavax conditional marketing authorization (CMA) for [...]

Subjects

Subjects :
Novavax Inc. -- Marketing
Biotechnology industry -- Marketing
Drug approval
Vaccines -- Marketing
Marketing
Company marketing practices
Pharmaceuticals and cosmetics industries
European Union
European Union. European Commission

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.687625395

Tools

Authors Abstract Subjects Details